| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.58 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.6 | 0.04 |